Filing Details
- Accession Number:
- 0001562180-22-006706
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-16 17:34:18
- Reporting Period:
- 2022-09-14
- Accepted Time:
- 2022-09-16 17:34:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654430 | Briggs Morrison | C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451 | President, Head Of R&D | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-14 | 87,645 | $7.20 | 105,481 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-14 | 87,645 | $23.80 | 17,836 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-15 | 66,775 | $7.20 | 84,611 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-15 | 66,775 | $24.20 | 17,836 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-16 | 71,966 | $7.20 | 89,802 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-16 | 71,966 | $23.22 | 17,836 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-16 | 53,034 | $10.90 | 70,870 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-16 | 53,034 | $23.22 | 17,836 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-14 | 87,645 | $0.00 | 87,645 | $7.20 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-15 | 66,775 | $0.00 | 66,775 | $7.20 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-16 | 53,034 | $0.00 | 53,034 | $10.90 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-16 | 71,966 | $0.00 | 71,966 | $7.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-06-30 | No | 4 | M | Direct | |
| 0 | 2025-06-30 | No | 4 | M | Direct | |
| 0 | 2025-09-09 | No | 4 | M | Direct | |
| 0 | 2025-06-30 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 948,946 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,042 options to purchase shares of common stock that have not yet vested.
- The sale prices ranged from $23.36 to $24.01
- The sale prices ranged from $23.36 to $24.64
- The sale prices ranged from $22.96 to $23.99
- This option is fully vested.
Billionaire Hedge Funds
